Bitcoin price today: falls to 2-week low below $113k ahead of Fed Jackson Hole
NEW YORK - Ardent Health Partners, Inc. (NYSE:ARDT) reported fourth-quarter earnings that surpassed analyst expectations, driven by strong revenue growth and the retroactive approval of a state payment program. The healthcare provider’s shares jumped 5.3% following the announcement and positive 2025 outlook.
Ardent Health reported fourth-quarter adjusted earnings per share of $0.81 on revenue of $1.61 billion, representing a 19% YoY increase. The company’s performance was bolstered by a 9.0% rise in adjusted admissions and a 9.5% growth in net patient service revenue per adjusted admission.
A key factor in the quarter’s success was the retroactive approval of the New Mexico state directed payment program, which contributed $94 million to total revenue and $65 million to Adjusted EBITDA. Excluding this benefit, the company’s performance remained in line with or favorable to its 2024 guidance.
"We had a strong finish to 2024, highlighted by reported revenue growth of 19% and Adjusted EBITDA growth of well over 200% in the fourth quarter," stated Marty Bonick, President and CEO of Ardent Health.
Looking ahead, Ardent Health provided an optimistic outlook for 2025, projecting revenue between $6.2 billion and $6.45 billion, with the midpoint slightly above the analyst consensus of $6.3 billion. The company expects Adjusted EBITDA to grow by 19% at the midpoint of its guidance range.
Bonick added, "We enter 2025 with strong momentum and see encouraging operating environment tailwinds with early indications that volume growth will remain durable this year."
The company’s positive results and forward-looking guidance have been well-received by investors, as reflected in the stock’s upward movement following the earnings release.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.